Patent focus on new anti-obesity agents: September 1999-February 2000

Expert Opinion on Therapeutic Patents

Volumn 10, Issue 6, 2000, Pages 819-831

  Carpino, P A ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

5 HT(2c); Mahogany gene; Melanocortin 4 receptor; Neuropeptide Y1 and Y5 receptor; NPY 7 receptor; Obesity; Orexin 1 receptor; Pancreatic lipase; Protein tyrosine phosphatase 1B; Receptor; 3 adrenoceptor

Indexed keywords

1 NAPHTHALENESULFONIC ACID [4 [(4 AMINO 2 QUINAZOLINYLAMINO)METHYL]CYCLOHEXYLMETHYL]AMIDE; ANTIOBESITY AGENT; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; BIEE 0246; DEXFENFLURAMINE; ENZYME INHIBITOR; FENFLURAMINE; J 104870; MELANOCORTIN RECEPTOR; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; N2 [[1 [2 [4 (5,11 DIHYDRO 6(6H) OXODIBENZ[B,E]AZEPIN 11 YL]PIPERAZINYL] 2 OXOETHYL]CYCLOPENTYL]ACETYL] N [2 (1,2 DIHYDRO 3,5 DIOXO 1,2 DIPHENYL 3H 1,2,4 TRIAZOL 4 YL]ETHYL]ARGINAMIDE; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR; OREXIN; PHENTERMINE; RO 60 0332; SEROTONIN UPTAKE INHIBITOR; SIBUTRAMINE; TETRAHYDROLIPSTATIN; TRG 2405 252; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; ENERGY BALANCE; FOOD INTAKE; GASTROINTESTINAL TRACT; HUMAN; NEUROENDOCRINE SYSTEM; NONHUMAN; OBESITY; REVIEW; SEROTONINERGIC SYSTEM; THERMOGENESIS; WEIGHT REDUCTION;

EID: 0034074194     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.10.6.819     Document Type: Review

References (66)